# FDA recall D-0127-2024

> **Teva Pharmaceuticals USA, Inc** · Class III · drug recall initiated 2023-11-10.

## Product

Testosterone Gel, 1.62% CIII (Alcohol 80% v/v), packaged in 30 unit-dose packets per carton, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0591-2926-30

## Reason for recall

OOS for viscosity

## Distribution

USA nationwide

## Key facts

- **Recall number:** D-0127-2024
- **Recalling firm:** Teva Pharmaceuticals USA, Inc
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2023-11-10
- **Report date:** 2023-12-06
- **Termination date:** 2024-06-03

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Parsippany, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0127-2024

## Citation

> AI Analytics. FDA recall D-0127-2024. Retrieved 2026-06-26 from https://api.ai-analytics.org/recall/D-0127-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*